People

Theralase®’s executive officers who drive Theralase’s mandate in the ACT and CLT divisions to develop innovative anti-cancer and anti-pain technologies via research, development and commercialization to safely and effectively treat cancer and pain patients.

> 20 years of hands-on experience in: pharmaceutical drug formulation and development, clinical trial management, good manufacturing practices, international drug manufacture, international regulatory guidelines and quality assurance.

> 25 years of experience in financial accounting and public and private financings for companies.

> 34 years experience as a clinical and scientific researcher of medical laser technology used to safely and effectively treat numerous medical conditions.

> 34 years experience as a clinical and scientific researcher of medical laser technology used to safely and effectively treat numerous medical conditions.

> 16 years of financial investing experience with Aligned Capital Partners and Investment Planning Counsel.

> 25 years of experience in financial accounting and public and private financings for companies.

> 13 years of financial investing experience with TD Waterhouse, BMO Nesbitt Burns and Bank of Nova Scotia.

Professor of Surgery (Urology) at the University of Toronto, a member of the Department of Surgical Oncology at Princess Margaret Cancer Centre (“PMCC”), University Health Network (“UHN”) and a clinical investigator at UHN. Chairman of the Division of Urology at the University of Toronto and Head of Urology at PMCC / UHN from 1991 to 2002.

Professor of Surgery (Urology), Director of Urologic Oncology Fellowship at MD Anderson Cancer Center and a graduate of the American Urological Association (“AUA”) Leadership Program. Internationally recognized expert in urologic oncology and an authority in the management of urologic cancers.

Professor of Surgery (Urology), University of Iowa. Basic and clinical research has a long history of focusing on bladder immunology and bladder cancer immunotherapy, particularly the anti-cancer mechanisms of Bacillus Calmette-Guérin (“BCG”) and its enhancement with combination therapies.

Professor of Medical Biophysics, University of Toronto, Senior Scientist Ontario Cancer Institute, PMCC, UHN

Senior Scientist and Head of the Applied Biophotonics group at PMCC, UHN, Professor of Medical Biophysics at the University of Toronto.

> 34 years experience as a clinical and scientific researcher of medical laser technology used to safely and effectively treat numerous medical conditions.

> 11 years experience as a scientific researcher, specializing in immunology, cardiovascular biology and phototherapy

> 20 years of hands-on experience in: pharmaceutical drug formulation and development, clinical trial management, good manufacturing practices, international drug manufacture, international regulatory guidelines and quality assurance.

> 34 years of experience as a chief executive officer / president / senior manager leading multi-disciplinary: sales, marketing, finance, production, engineering, scientific, preclinical and clinical research teams for private and public companies. Original founder of Theralase Inc. in 1994.

> 20 years of experience as an senior electrical design engineer, specializing in medical laser research, design and manufacture (hardware, firmware and software)

> 2 years of experience as a biomedical technologist, specializing in medical laser manufacture and testing (hardware, firmware and software)

> 1 year of experience as a biomedical technologist, specializing in medical laser manufacture and testing (hardware and software) and phantom manufacture and testing

> 12 years of experience as a production technician, specializing in computer and software control of CLT systems

> 6 years of experience as a production technician, specializing in CLT manufacture and repair

Theralase® is dedicated to providing a stimulating work environment that offers an opportunity to significantly expand your experience by researching, developing and commercializing cutting-edge medical laser technologies with a mandate to eliminate pain and destroy cancer. Theralase® offers competitive salaries, annual performance bonuses, employee benefits and/or stock options.